molnupiravir

Researchers said that both oral antiviral drugs can be used to treat nonhospitalized patients at high risk of progressing to severe COVID-19.

The COVID-19 antiviral drug Molnupiravir helps speed up recovery from the virus but does not reduce the hospitalization or ...

A study conducted by Hong Kong University (HKU) Medical School found that two oral drugs, molnupiravir and ritonavir-boosted ...

Merck & Co said on Wednesday it expects its 2022 sales to increase as much as 18 percent ...

Merck's COVID-19 oral pill molnupiravir has a mechanism of action that can work against Omicron and any other ...

Indian multinational pharmaceutical company Dr. Reddy’s Laboratories will be launching a generic version of Merck's COVID-19 oral antiviral ...

BENGALURU—India has approved Merck's COVID-19 pill and two more vaccines for emergency use as the world's second-most populous ...

PARIS—France has canceled its order for Merck & Co.'s COVID-19 antiviral drug following disappointing trial data and hopes ...

Outside advisers to the U.S. Food and Drug Administration (FDA) on Tuesday narrowly voted to recommend the agency ...

GENEVA—The World Health Organization (WHO) said on Thursday that it was seeking further data from Merck on its ...

AMSTERDAM—The pharmaceutical company Merck says it has asked the European Medicines Agency to authorize its COVID-19 antiviral treatment, ...